Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
LIVE
BSE
May 24, 17:00
390.30
-2.85 (-0.72%)VOLUME 206,975
LIVE
NSE
May 24, 17:00
389.70
-4.6 (-1.17%) VOLUME 1,613,901
Nine Months of Ranbaxy Laboratories |
------------------- in Rs. Cr. ------------------- |
 | ||||||||||
|
||||||||||
| Sep '12 | Sep '11 | Sep '10 | Sep '09 | Sep '08 | ||||||
|
||||||||||
| Net Sales/Income from operations | 4,711.02 | 3,646.91 | 4,570.74 | 3,279.53 | 3,542.23 | |||||
| Other Operating Income | 151.01 | 155.49 | -- | -- | -- | |||||
| Total Income From Operations | 4,862.02 | 3,802.40 | 4,570.74 | -- | -- | |||||
| EXPENDITURE | ||||||||||
| Consumption of Raw Materials | 1,119.74 | 1,406.94 | 1,254.79 | 1,158.31 | 1,240.76 | |||||
| Purchase of Traded Goods | 618.36 | 460.72 | -- | -- | -- | |||||
| Increase/Decrease in Stocks | -39.28 | -168.94 | -149.27 | -87.91 | -155.59 | |||||
| Power & Fuel | -- | -- | -- | -- | -- | |||||
| Employees Cost | 756.10 | 678.00 | 583.41 | 548.84 | 374.04 | |||||
| Depreciation | 139.77 | 142.55 | 163.40 | 92.22 | 91.64 | |||||
| Excise Duty | -- | -- | -- | 11.16 | 24.23 | |||||
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |||||
| R & D Expenses | -- | -- | -- | -- | 309.26 | |||||
| Provisions And Contingencies | -- | -- | -- | -- | -- | |||||
| Exp. Capitalised | -- | -- | -- | -- | -- | |||||
| Other Expenses | 1,859.06 | 1,519.90 | 1,574.59 | 1,555.79 | 1,807.81 | |||||
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 408.27 | -236.77 | 1,143.82 | -- | -- | |||||
| Other Income | 172.49 | 226.67 | 438.53 | 149.89 | 29.47 | |||||
| P/L Before Int., Excpt. Items & Tax | 580.76 | -10.10 | 1,582.35 | -- | -- | |||||
| Interest | 162.70 | 41.88 | 155.58 | 33.99 | 109.11 | |||||
| P/L Before Exceptional Items & Tax | 418.07 | -51.98 | 1,426.77 | -- | -- | |||||
| Exceptional Items | 35.69 | -286.37 | -- | -- | -- | |||||
| P/L Before Tax | 453.76 | -338.35 | 1,426.77 | -- | -- | |||||
| Tax | -- | 3.38 | 415.84 | 23.01 | -158.41 | |||||
| P/L After Tax from Ordinary Activities | 453.76 | -341.73 | 1,010.93 | -- | -- | |||||
| Prior Year Adjustments | -- | -- | -- | -10.26 | -- | |||||
| Extra Ordinary Items | -- | -- | 82.56 | -- | -154.62 | |||||
| Net Profit/(Loss) For the Period | 453.76 | -341.73 | 1,093.49 | 83.75 | -225.78 | |||||
| Equity Share Capital | 211.13 | 210.75 | 210.38 | 210.19 | 187.04 | |||||
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |||||
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |||||
| EPS Before Extra Ordinary | ||||||||||
| Basic EPS | 10.76 | -8.11 | 26.00 | -- | -- | |||||
| Diluted EPS | 10.72 | -8.11 | 22.79 | -- | -- | |||||
| EPS After Extra Ordinary | ||||||||||
| Basic EPS | 10.76 | -8.11 | 26.00 | -- | -- | |||||
| Diluted EPS | 10.72 | -8.11 | 22.79 | -- | -- | |||||
| Public Share Holding | ||||||||||
| No Of Shares (Crores) | 14.50 | 14.55 | 14.62 | 14.53 | 23.86 | |||||
| Share Holding (%) | 34.35 | 34.51 | 34.75 | 34.57 | 63.77 | |||||
| Promoters and Promoter Group Shareholding | ||||||||||
| a) Pledged/Encumbered | ||||||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |||||
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |||||
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |||||
| b) Non-encumbered | ||||||||||
| - Number of shares (Crores) | 26.87 | 26.87 | 26.87 | -- | -- | |||||
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | 100.00 | 100.00 | 100.00 | -- | -- | |||||
| - Per. of shares (as a % of the total Share Cap. of the company) | 63.64 | 63.75 | 63.86 | -- | -- | |||||
| Notes | ||||||||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| ||||||||||
Results of Ranbaxy Labs
- News
- Results
- Estimates
- Analysis
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
Quick Links for ranbaxylaboratories
Related Searches
ranbaxylaboratories Stock Price, Ranbaxy%20Labs Stock Quote, Ranbaxy%20Labs Results , Ranbaxy%20Labs News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
India's Premiere Technology Guide |
History India | Davos
| Etihad Airways | Natural gas | Indian rupee | SpiceJet | BANGALORE | Manmohan Singh | Mobile app | Jaypee Group | Idea Cellular Limited | FICCI
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.